Kodiak Sciences: A Stellar Move [Seeking Alpha]
Kodiak Sciences Inc (KOD)
Last kodiak sciences inc earnings: 11/12 05:30 am
Check Earnings Report
Company Research
Source: Seeking Alpha
KOD's pipeline targets major retinal diseases, with pivotal Phase 3 data for tarcocimab, KSI-501, and KSI-101 expected between 2026 and 2027. Recent secondary raised over $170 million, extending cash runway into 2H27; Baker Bros. increased stake to 33% during the offering. An updated analysis around Kodiak Sciences follows in the paragraphs below. Looking for a helping hand in the market? Members of The Biotech Forum get exclusive ideas and guidance to navigate any climate. Learn More » Torsten Asmus/iStock via Getty Images Shares of vision loss treatment concern Kodiak Sciences Inc. ( KOD have staged a massive rally off of their 52-week low set in April 2025, thanks to encouraging data from asset KSI-101 and its competitor. The IL-6/VEGF More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just ini
Show less
Read more
Impact Snapshot
Event Time:
KOD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KOD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KOD alerts
High impacting Kodiak Sciences Inc news events
Weekly update
A roundup of the hottest topics
KOD
News
- Kodiak Sciences (NASDAQ:KOD) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- 3 Small-Cap Blend Mutual Funds With Strong Growth Potential [Yahoo! Finance]Yahoo! Finance
- Is It Too Late To Consider Kodiak Sciences (KOD) After Its 233% One-Year Surge? [Yahoo! Finance]Yahoo! Finance
- Kodiak Sciences (NASDAQ:KOD) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
- Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
KOD
Earnings
- 11/13/25 - Miss
KOD
Sec Filings
- 12/19/25 - Form SCHEDULE
- 12/19/25 - Form 4
- 12/18/25 - Form 8-K
- KOD's page on the SEC website